miRNA-1226: As a Potential Diagnostic Marker in FFPE Tissue of Breast Cancer
Zanco Journal of Pure and Applied Sciences · 30.04.2026 · 38 (2) · 42-49
DOI: 10.21271/zjpas.38.2.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zanco Journal of Pure and Applied Sciences, online erschienen am 30.04.2026. Verfasst von Shayan Rasheed Abubakir. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Backgrounds: Researchers have just commenced the exploration of miRNAs as a prospective new class of biomarkers. This study investigates the potential of miR-1226 as a significant prognostic factor for BC.
Methods
The miR-1226 expression was detected in 30 pairs of FFPE tissues using qRT-PCR. The clinicopathological characteristics of patients regarding miR-1226 expression, together with fold change analysis using the 2-ΔΔCT method, were further investigated. All statistical analyses were performed with GraphPad and MedCalc.
Results
We found that the miR-1226 level in BC FFPE tissues is slightly increased compared to control tissues. Also, we examined the relationship associated with clinicopathological features and miR-1226 expression levels of BC patients. This investigation revealed no significant association between miR-1226 expression levels and the clinical progression. Age, lymph node involvement, and Ki-67 expression had no significant correlation with outcome status. No significant relationships were observed between tumor-related factors such as grade and size. The hormone receptor status, PR status, and HER-2 status did not exhibit a significant correlation with outcome stratification. The trend regarding PR status may necessitate additional examination for its prognostic significance. Moreover, the p-value, AUC, and Std. Error, sensitivity, and specificity are (p < 0.006, 0.684,0.0723, 83.3, and 60, respectively), which signifies a moderate capacity of the test to differentiate between tumors and controls. The results of fold change analysis employing the 2-ΔΔCT method indicated a (1)-fold elevation in miR-1226 expression in tumors relative to controls.
Conclusions
We demonstrated that a slight elevation of miR-1226 expression correlates with the progression of BC, and this indicates that miR-1226 may possess an oncogenic function in BC tumorigenesis and progression.
Zitieren
APA
Abubakir, S. R. (2026). miRNA-1226: As a Potential Diagnostic Marker in FFPE Tissue of Breast Cancer. Zanco Journal of Pure and Applied Sciences, 38(2), 42-49. https://doi.org/10.21271/zjpas.38.2.3
Vancouver
Abubakir SR. miRNA-1226: As a Potential Diagnostic Marker in FFPE Tissue of Breast Cancer. Zanco Journal of Pure and Applied Sciences. 2026;38(2):42-49. doi:10.21271/zjpas.38.2.3
BibTeX
@article{Abubakir2026,
author = {Abubakir, Shayan Rasheed},
title = {miRNA-1226: As a Potential Diagnostic Marker in FFPE Tissue of Breast Cancer},
journal = {Zanco Journal of Pure and Applied Sciences},
year = {2026},
volume = {38},
number = {2},
pages = {42--49},
doi = {10.21271/zjpas.38.2.3}
}
EUVIMED